of our analyses is to evaluate the feasibility of using a national electronic health record (EHR) range from 5 to 10 mg/L, and trough levels should be <2 mg/L (7).
37
Gentamicin population PK models have been developed for infants in previous studies.
38
Both 2-and 3-compartment models were used to characterize gentamicin's disposition in infants
39
(8-12). Since gentamicin is almost entirely renally eliminated, age, weight, and serum creatinine
40
(SCR) concentration were commonly identified as important covariates on gentamicin clearance.
41
These publications either did not perform an external evaluation or performed an evaluation 42 using an external dataset consisting of 70 to ~160 subjects (7-11).
43
Unlike the traditional clinical trials that are challenging to perform in children due to the 44 ethical, logistical and financial factors, electronic health record (EHR) data allow researchers to 45 access large volumes of clinical data easily and efficiently (13). The large sample size and 46 widely distributed profiles in EHR data make it an ideal data source for evaluation of PK models.
47
In previous studies, EHR data had been used to develop PK models or assess the relationship 48 between drug exposure and safety (14, 15). However, to date we are not aware of any studies that 49 have used a national EHR database data to externally evaluate a population PK model. The 50 objective of this paper is to use gentamicin as a case study to explore the potential use of EHR 51 data in the evaluation of population PK models.
52
In this study, EHR data from 348 Pediatrix Medical Group neonatal intensive care units 53 from 1997 to 2014 was used to evaluate a previously reported gentamicin population PK model. 
60
The following assumptions and criteria were used to extract relevant and reliable EHR 
86
The packages xpose4 and lattice packages in R and RStudio were used for data visualization
87
(16-18). Visual predictive checks (VPC) were performed based on 1000 simulations using Perl- (Figure 2) 
